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Abstract
Introduction: Vanishing white matter disease (VWM) is considered as one of the most frequent types of inherited childhood
leukoencephalopathies. Various neurological and non-neurological manifestations have been reported in this type of leukodys-
trophy; however, seizures are rarely described in infantile type of VWM.
Case Presentation: To patient is a 12 months old boy who experienced frequent seizures at 4th month of age. The seizures were
resistant to anti-epileptic drugs and caused 3 periods of hospitalization. Magnetic resonance imaging (MRI) demonstrated demyeli-
nating pattern and whole exome sequencing (WES) reported homozygous mutation (c.922G > A) in EIF2B2 gene in exon 8 leading to
an amino-acid substitution (p.Val308Met).
Conclusions: Infantile onset of vanishing white matter disease can be considered as one of few childhood leukodystrophies that
are associated with early onset seizures.
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1. Introduction
Childhood leukodystrophies consist of various inher-
ited white matter disorders with an incidence ranging
from 1.2 to 3.01 per 100,000 persons/year (1). Vanishing
white matter disease (VWM) is an autosomal recessive dis-
order and one of the most common types of leukodystro-
phies and engages all ages including antenatal, infantile,
early childhood, late childhood, and adults (2). No data
exists regarding the exact incidence of VWM; however, it
seems that this type of leukodystrophy is more common
in Caucasians. It has also been reported in non-white cases
from South America and Asia.
The molecular basis of the disease has been shown to
be due to mutations in any of the five genes encoding sub-
units of eukaryotic translation initiation factor B (eiF2B).
These genes are known as EIF2B1-5. EIF2B is considered as
an important molecule which plays a significant role in the
protein synthesis and managing the cellular stress condi-
tions. To date, more than 110 mutations have been discov-
ered in EIF2B genes; mostly recognized in EIF2B5, followed
by EIF2B4 and EIF2B2 genes (3).
The infantile form of the disease appears before the age
of 2 years and usually is determined by hypotonia, progres-
sive neurological deterioration, cerebellar ataxia, early on-
set cataracts, spasticity, fever and vomiting (3). Moreover,
only few cases of early onset or infantile type of vanishing
white matter disease with refractory seizures have been re-
ported (2, 3).
Here, we report the clinical and radiologic findings of
a boy with infantile type of vanishing white matter dis-
ease who was presented with early onset serial seizures at
4 months of age. Molecular genetic evaluations indicated
a mutation in EIF2B2 gene which confirmed the disease.
2. Case Presentation
The patient is a 12 month old boy who was born at
term to a consanguinous couple with birth weight of
2550 grams and head circumference of 34cm. His parents
brought him to a primary care physician at 2 months of age
due to his poor weight gain. At 4 months, frequent seizures
with staring, clonic movements of the left side limbs and
truncal hypotonia developed. Therefore, the patient was
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referred to our hospital (children’s Medical center) for fur-
ther evaluation. Neurological examinations did not show
spasticity nor exaggerated deep tendon reflexes, but ax-
ial hypotonia was present. Neurological deterioration was
not recognized. Awake electroencephalography (EEG) at
age of 4 months showed tonic and focal seizures consisting
of flattening of the background preceded by generalized
and multifocal spike waves followed by diffuse slow waves.
Brain magnetic resonance imaging (MRI) was performed
at the time of seizure onset for further evaluation (Figure
1). Brain MRI transverse spin echo (SE) T2 weighted images
at the level of midbrain and high parietal centrum semi-
oval demonstrated diffuse abnormally increased signal of
deep and subcortical white matter. In addition, bilateral
higher signal of anterior temporal subcortical white mat-
ter in T2 weighted image compared to deep white matter
suggested early cystic degeneration in these areas. Coro-
nal SE T2 weighted image and T1 fluid attenuated inver-
sion recovery (FLAIR) sequences at the level of posterior
limb of internal capsule and dentate nuclei indicated dif-
fuse supra and infratentorial white matter increased sig-
nals which were relatively low in T1 FLAIR. Overall find-
ings were consistent with severe demyelination of white
matter. We considered a demyelinating type of childhood
leukodystrophy as the probable etiology for the clinical
scenario of this patient regarding to MRI pattern involve-
ment, early onset refractory seizures and global develop-
mental delay. Seizures of the patient stopped with intra-
venous anti-epileptic medications and he was discharged 2
weeks later with phenobarbital. Basic metabolic tests were
all normal; therefore performing of molecular study was
discussed with parents to establish the diagnosis.
In his follow-up, truncal tone was improved with oc-
cupational therapy at the age of 6 months; however, he
experienced frequent tonic seizures unresponsive to anti-
epileptic drugs at 7 months of age. Therefore, the patient
was admitted to pediatric intensive care unit (PICU) of our
hospital for 1 month for better control of seizures. The pa-
tient was discharged from the hospital with oral phenobar-
bital, phenytoin and levetiracetam. By obtaining informed
consent from parents blood sample of the patient was sent
to laboratory for molecular studies.
Two weeks later at the age of 8.5 months the patient
was hospitalized again with decreased level of conscious-
ness and 5 to 6 times of tonic seizures per day. Meanwhile,
he experienced respiratory failure in PICU. Intubation was
performed; followed by tracheostomy due to long term in-
tubation.
And now, at the age of 12 months, the patient is dis-
charged from hospital and his seizures are under con-
trol by phenobarbital, topiramate, lamotrigine, and oxcar-
bazepine. His respiration is supported by mechanical ven-
tilation through T-tube and oxygen therapy. The last sys-
temic and neurologic examinations showed central hypo-
tonia, microcephaly, dense cataract, global developmental
delay and poor weight gain. The results of molecular stud-
ies at age 12 months showed the final diagnosis.
2.1. Whole Exome Sequencing
Genomic DNA was extracted from peripheral blood
using standard protocols. Coding regions and exon-
intron boundaries were enriched using Agilent Sure-
Select Human All Exon 50 Mb (Agilent Technologies
Santa Clara, CA) according to the manufacturer’s
standard protocol. Sequencing was performed by
targeted-next generation sequencing (NGS) analyzer
on an Illumina, Hiseq4000 (Illumina, San Diego, Cal-
ifornia, USA). Burrows-Wheeler Aligner (BWA), GATK
(https://www.broadinstitute.org/gatk/) software pack-
age and SAMTools were applied to align the reads us-
ing on reference genome (hg19), variant calling and
for annotation. The variants were filtered based on
their frequency (minor allele frequency < 0.1) in 1000
Genome ExAC (http://exac.broadinstitute.org/) and
dbSNP and EVS (http://evs.gs.washington.edu/EVS/)
databases. Some online software tools includ-
ing Combined Annotation Dependent Deple-
tion (CADD) (http://cadd.gs.washington.edu/),
Polyphen2 (http://genetics.bwh.harvard.edu/pph2/),
SIFT (http://sift.jcvi.org/) and MutationTaster
(http://www.mutationtaster.org/). The standards and
guidelines for the interpretation of sequence variants
based on consensus recommendation of the American
college of Medical genetics and genomics (ACMG) 2015
was also used to interpret the variants (4). The proband,
his parents and sister were analyzed for the found variant
using Sanger sequencing. Those variants that segre-
gated with the phenotype within the entire family were
considered pathogenic.
A homozygous variant (c.922G > A) (rs372548739) was
detected in EIF2B2 gene in exon 8 leading to an amino acid
substitution (p.Val308Met). Sanger sequencing at position
c.922 of his clinically asymptomatic parents revealed a het-
erozygous mutation but his sister was normal for this po-
sition; the segregation analysis confirmed the result. In ad-
dition, above mentioned software tools predicted this vari-
ant as disease causing.
3. Discussion
Frequent seizures were the main manifestation in this
patient. As seizure occurrs in rare cases of infantile VWM,
suspecting this type of leukodystrophy as a potential diag-
nosis in the early stage of the disease in this patient was
not possible. To date, no specific algorithmic approach
has been introduced for diagnosis of leukodystrophies.
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Figure 1. A, B, Brain magnetic resonance imaging (MRI) Transverse spin echo (SE) T2 weighted images at the level of midbrain and high parietal centrum semi-ovale demon-
strated diffuse abnormal increased signal of deep and subcortical white matter. Note bilateral higher signal of anterior temporal subcortical white matter in T2 weighted
image comparing deep white matter which suggests early cystic degeneration in these areas (white arrows). C, D, Coronal SE T2 weighted image and T1 fluid attenuated inver-
sion recovery (FLAIR) sequences at the level of posterior limb of internal capsule and dentate nuclei indicated diffuse supra and infratentorial white matter increased signal
in T2 weighted image which is respectively low in T1 FLAIR. Overall findings are consistent with severe demyelination of white matter.
However, clinical scenario of individuals, imaging findings
and MRI pattern involvement, and genetic tests are the
three main dimensions for diagnosis. In this study, the
most common clinical presentations of VWM were not ob-
served in the early stage of the disease, but hypotonia. It
took about 8 months after the first episodes of seizures
until other clinical features; including microcephaly and
cataract, were recognized. Up to now features like spastic-
ity, ataxia and fever have not been observed. Although the
overall clinical presentations were confusing and couldn’t
lead to diagnosis, demyelinating pattern in MRI and re-
ported homozygous mutation in EIF2B2 gene make the di-
agnosis of VWM definite. It is worth to mention that al-
though genetic analysis is the most suitable modality for
diagnosis of VWM and other types of leukodystrophies; its
high cost and late response are the biggest challenges of its
use. Therefore, to reduce the economic burden of diagno-
sis of leukodystrophies one should focus more on clinical
presentations and imaging MRI findings as much as possi-
ble.
To date only few cases of early onset VWD have been re-
ported in whom frequent seizures have been prominent as
clinical manifestations of the disease. These are listed in Ta-
ble 1. In one study epilepsy occurrence coincided with var-
ious other manifestations of VWD (5); yet another one re-
ported seizure as the only clinical manifestation (6). Like
our study, 2 of these trials reported mutations in EIF2B2
gene. However, the DNA levels of mutation were different.
Leng et al. (7) reported a patient with a compound het-
erozygous mutation in EIF2B2gene that caused by c.254T4A,
p. Val85Gly mutation in father and c.922G4A, p.Val308Met
mutation in mother; however, homozygosity of the muta-
tions in our patient is due to consanguineous marriage of
his parents.
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Table 1. Case Report Studies Reporting Seizure as a Manifestation in Infantile form of Vanishing White Matter Disease
Study Identification Clinical Features Mutation
Takano et al. (2) A 4 month-old girl who developed lethargy, vomiting and seizure as
well as rapid neurological deterioration.
Two heterozygous mutations in the EIF2B5 gene (c.584G > A and
c.1223T > C).
Hata et al. (8) Physical and mental development of a boy began to deteriorate after
convulsions at 10 months of age. A marked decrease in volume of
white matter, with no typical cystic rarefaction was observed.
Submicroscopic deletion of 14q24.3, which included EIF2B2 and a
missense mutation of EIF2B2 (V85E) of the remaining allele.
Shimada et al. (5) A 2-year-old boy with progressive developmental deterioration
associated with intractable epilepsy at 11 months of age, which was
triggered by recurrent acute infectious diseases. Small palpebral
fissures, bushy eyebrows, ear abnormalities, small upturned nose,
downturned corners of the mouth, and micrognathia were other
identified characteristic features.
Deletion at 14q24.3 that included EIF2B2.
Gungor et al. (6) A 12 months old boy presented with intractable seizures since he was
3 months of age. He had intractable and prolonged seizures during
the course of his disease.
Homozygote c.1091G > A mutation at the EIF2B4 gene
The study was approved by ethics committee of chil-
dren’s hospital center, pediatric center of excellence.
3.1. Conclusion
Infantile type of VWD in association with some types
of childhood leukodystrophies including type I Alexander
disease, Aicardi-Goutieres syndrome, Canavan disease and
Krabbe disease (9) can be considered as those leukodystro-
phies of pediatric population that are associated with early
onset seizures in their clinical manifestations.
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